Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1M...DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML)
USFDA APPLICATION NUMBER - 203629
DOSAGE - SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/...DOSAGE - SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML)
USFDA APPLICATION NUMBER - 203629
DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5...DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 203629
DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1M...DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML)
USFDA APPLICATION NUMBER - 204078
DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5...DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 204078
DOSAGE - SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/...DOSAGE - SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/ML)
USFDA APPLICATION NUMBER - 204078
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
60
PharmaCompass offers a list of Neostigmine Methylsulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Neostigmine Methylsulfate manufacturer or Neostigmine Methylsulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neostigmine Methylsulfate manufacturer or Neostigmine Methylsulfate supplier.
PharmaCompass also assists you with knowing the Neostigmine Methylsulfate API Price utilized in the formulation of products. Neostigmine Methylsulfate API Price is not always fixed or binding as the Neostigmine Methylsulfate Price is obtained through a variety of data sources. The Neostigmine Methylsulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate, including repackagers and relabelers. The FDA regulates Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate supplier is an individual or a company that provides Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate active pharmaceutical ingredient (API) or Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate finished formulations upon request. The Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers may include Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API manufacturers, exporters, distributors and traders.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate active pharmaceutical ingredient (API) in detail. Different forms of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate DMFs exist exist since differing nations have different regulations, such as Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate DMF submitted to regulatory agencies in the US is known as a USDMF. Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate USDMF includes data on Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate Drug Master File in Japan (Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate JDMF) empowers Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate JDMF during the approval evaluation for pharmaceutical products. At the time of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with JDMF on PharmaCompass.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP of the European Pharmacopoeia monograph is often referred to as a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate Certificate of Suitability (COS). The purpose of a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate to their clients by showing that a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP has been issued for it. The manufacturer submits a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP holder for the record. Additionally, the data presented in the Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate DMF.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with CEP (COS) on PharmaCompass.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate written confirmation (Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate WC) is an official document issued by a regulatory agency to a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturer, verifying that the manufacturing facility of a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate APIs or Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate WC (written confirmation) as part of the regulatory process.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with NDC on PharmaCompass.
Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate GMP manufacturer or Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate GMP API supplier for your needs.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CoA (Certificate of Analysis) is a formal document that attests to Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate's compliance with Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate specifications and serves as a tool for batch-level quality control.
Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CoA mostly includes findings from lab analyses of a specific batch. For each Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate EP), Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate USP).
